Several cancer-related signaling pathways have been reported to be activated by TRIM14, such as AKT pathway in osteosarcoma [6], NF-κB pathway in TSCC [8], Wnt/β-catenin pathway in glioma [10] and STAT3 in breast cancer [9]. Here, NFKB1 is linked to osteosarcoma.